Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of anti-inflammatory and central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of both hydroxyl and trifluoromethyl groups, which enhance metabolic stability and binding affinity. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies. Also utilized in the preparation of chiral building blocks for asymmetric synthesis.